Literature DB >> 3827361

Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients.

B Nordlinger, M A Quilichini, R Parc, L Hannoun, E Delva, C Huguet.   

Abstract

This report analyses an experience with 80 liver resections for metastatic colorectal carcinoma. Primary colorectal cancers had all been resected. Liver metastases were solitary in 44 patients, multiple in 36 patients, unilobar in 76 patients, and bilobar in 4 patients. Tumor size was less than 5 cm in 33 patients, 5-10 cm in 30 patients, and larger than 10 cm in 17 patients. There were 43 synchronous and 37 metachronous liver metastases with a delay of 2-70 months. The surgical procedures included more major liver resections (55 patients) than wedge resections (25 patients). Portal triad occlusion was used in most cases, and complete vascular exclusion of the liver was performed for resection of the larger tumors. In-hospital mortality rate was 5%. Three- and 5-year survival rates were 40.5% and 24.9%, respectively. None of the analysed criteria: size and number of liver metastases, delay after diagnosis of the primary cancer, Duke's stage, could differentiate long survivors from patients who did not benefit much from liver surgery due to early recurrence. Recurrences were observed in 51 patients during the study, two thirds occurring during the first year after liver surgery. Eight patients had resection of "secondary" metastases after a first liver resection: two patients for extrahepatic recurrences and six patients for liver recurrences. Encouraging results raise the question of how far agressive surgery for liver metastases should go.

Entities:  

Mesh:

Year:  1987        PMID: 3827361      PMCID: PMC1492710          DOI: 10.1097/00000658-198703000-00007

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

1.  The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy.

Authors:  S Bengmark; L Hafström
Journal:  Cancer       Date:  1969-01       Impact factor: 6.860

2.  Hepatic resection of metastatic colorectal carcinoma: a ten-year experience.

Authors:  S E Logan; S J Meier; K P Ramming; D L Morton; W P Longmire
Journal:  Arch Surg       Date:  1982-01

3.  Major hepatic resections for metastatic colorectal cancer.

Authors:  M A Adson; J A Van Heerden
Journal:  Ann Surg       Date:  1980-05       Impact factor: 12.969

4.  Hemodynamic and biochemical monitoring during major liver resection with use of hepatic vascular exclusion.

Authors:  E Delva; J P Barberousse; B Nordlinger; J M Ollivier; B Vacher; C Guilmet; C Huguet
Journal:  Surgery       Date:  1984-03       Impact factor: 3.982

5.  Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases.

Authors:  H J Wanebo; C Semoglou; F Attiyeh; M J Stearns
Journal:  Am J Surg       Date:  1978-01       Impact factor: 2.565

6.  [Surgical resection of hepatic metastases of cancers of the colon and rectum].

Authors:  B Nordlinger; G De Sena; A Szawlowski; J G Orea Martinez; R Parc; M Malafosse; C Huguet
Journal:  Gastroenterol Clin Biol       Date:  1983-03

7.  Tolerance of the human liver to prolonged normothermic ischemia. A biological study of 20 patients submitted to extensive hepatectomy.

Authors:  C Huguet; B Nordlinger; P Bloch; J Conard
Journal:  Arch Surg       Date:  1978-12

8.  Hepatic resection for metastases of the colon and rectum.

Authors:  J Butler; F F Attiyeh; J M Daly
Journal:  Surg Gynecol Obstet       Date:  1986-02

9.  Normothermic hepatic vascular exclusion for extensive hepatectomy.

Authors:  C Huguet; B Nordlinger; J J Galopin; P Bloch; D Gallot
Journal:  Surg Gynecol Obstet       Date:  1978-11

10.  Hepatic resection for trauma, tumour and biliary obstruction.

Authors:  L H Blumgart; J K Drury; C B Wood
Journal:  Br J Surg       Date:  1979-11       Impact factor: 6.939

View more
  63 in total

1.  Hepatic resection at a community hospital.

Authors:  M E Ston; S U Rehman; G Conaway; A Sardi
Journal:  J Gastrointest Surg       Date:  2000 Jul-Aug       Impact factor: 3.452

2.  LIVER RESECTION FOR METASTASES FROM COLORECTAL CANCER.

Authors:  H G Mukhopadhyay; L S Vohra; A K Sharma; R Solanki; P S Reddy; G S Chopra; P Subhas
Journal:  Med J Armed Forces India       Date:  2017-06-26

3.  Impact of advanced age on the outcome of liver resection.

Authors:  Luca Aldrighetti; Marcella Arru; Roberto Caterini; Renato Finazzi; Laura Comotti; Giorgio Torri; Gianfranco Ferla
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

4.  Surgical management of colorectal liver metastases.

Authors:  Waleed M Mohammad; Fady K Balaa
Journal:  Clin Colon Rectal Surg       Date:  2009-11

Review 5.  Resection of colorectal liver metastases revisited.

Authors:  J Scheele; C Rudroff; A Altendorf-Hofmann
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

6.  Hepatic resection in the elderly.

Authors:  J G Fortner; R M Lincer
Journal:  Ann Surg       Date:  1990-02       Impact factor: 12.969

7.  Perioperative predictors of morbidity following hepatic resection for neoplasm. A multivariate analysis of a single surgeon experience with 105 patients.

Authors:  J V Sitzmann; P S Greene
Journal:  Ann Surg       Date:  1994-01       Impact factor: 12.969

8.  Repeat hepatic surgery for colorectal cancer metastasis to the liver.

Authors:  C W Pinson; J K Wright; W C Chapman; C L Garrard; T K Blair; J L Sawyers
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

Review 9.  Resection of hepatic metastases from colorectal cancer. Biologic perspective.

Authors:  G Steele; T S Ravikumar
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

10.  Practical questions in liver metastases of colorectal cancer: general principles of treatment.

Authors:  Héctor Daniel González; Joan Figueras
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.